http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2009137794-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 |
| filingDate | 2008-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2009137794-A |
| titleOfInvention | DISSOLVING TO MOUTH TABLET |
| abstract | 1. A mouth disintegrating tablet containing (1) D-mannitol, (2) an active ingredient, (3) one or more disintegrating agents selected from the group consisting of crospovidone and carmellose, and (4) one or more lubricants selected from the group consisting of sodium stearyl fumarate and sucrose fatty acid esters. ! 2. A tablet disintegrating in the mouth according to claim 1, wherein the disintegrant is crospovidone. ! 3. A disintegrating oral tablet according to claim 1, wherein the lubricant is sodium stearyl fumarate. ! 4. A tablet disintegrating in the mouth according to any one of claims 1 or 2, wherein the disintegrant is present in an amount of from 1 to 10% by weight. ! 5. A disintegrating oral tablet according to any one of claims 1 or 3, wherein the lubricant is present in an amount of from 0.01 to 5% by weight. ! 6. The oral disintegrating tablet according to claim 1, wherein the D-mannitol has an average particle size of greater than 10 microns and equal to or less than 500 microns. ! 7. The disintegrating oral tablet of claim 2, wherein the lubricant is sodium stearyl fumarate. ! 8. The disintegrating oral tablet of claim 7, wherein the D-mannitol has an average particle size of greater than 10 microns and equal to or less than 500 microns. ! 9. The oral disintegrating tablet according to claim 1, wherein the D-mannitol has an average particle size of greater than 30 μm and a specific surface area of greater than 0.40 m2 / g. ! 10. The disintegrating oral tablet of claim 1, wherein the D-mannitol is a β type crystal. ! 11. The disintegrating oral tablet according to claim 1, further comprising a binder. ! 12. The oral disintegrating tablet of claim 11, wherein the binder is one or more members selected from the group consisting of hydroxypropyl cellulose and pregelatinized starch. ! 13. The disintegrating oral tablet of claim 12, wherein |
| priorityDate | 2007-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.